Endothelial cell loss and graft survival after Descemet's stripping automated endothelial keratoplasty and penetrating keratoplasty

Ophthalmology. 2012 Nov;119(11):2239-44. doi: 10.1016/j.ophtha.2012.06.012. Epub 2012 Aug 9.

Abstract

Purpose: We sought to compare endothelial cell (EC) loss and graft survival after Descemet's stripping automated endothelial keratoplasty (DSAEK) and conventional penetrating keratoplasty (PK) in Asian eyes.

Design: Retrospective, nested, cohort study.

Participants: Consecutive patients who underwent DSAEK or PK with Fuchs' endothelial dystrophy or pseudophakic and aphakic bullous keratopathy (BK) at a single tertiary center from April 1, 2006, to April 1, 2008.

Methods: Clinical data, and donor and recipient characteristics were recorded from our prospective cohort from the Singapore Corneal Transplant Study.

Main outcome measures: Percent EC loss and graft survival up to 3 years.

Results: There were no differences in baseline characteristics of patients comparing DSAEK and PK; there were more patients with BK (n = 141, 68.4%) than Fuchs' dystrophy. Percent EC loss was lower in DSAEK compared with PK at 1 (30 ± 22% vs 37 ± 25%; P = 0.045), 2 (36 ± 23% vs 45 ± 33%; P = 0.018), and 3 years (39 ± 24% vs 47 ± 28%; P = 0.022) postoperatively. Graft survival was comparable (log-rank P = 0.671) between DSAEK and PK at 1 (94% vs 90%), 2 (88% vs 85%), and 3 years (87% vs 85%).

Conclusions: Compared with PK, DSAEK resulted in lower EC loss with comparable cumulative graft survival rates for up to 3 years in patients with Fuchs' dystrophy and BK.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Case-Control Studies
  • Cell Count
  • Corneal Endothelial Cell Loss / diagnosis*
  • Descemet Stripping Endothelial Keratoplasty*
  • Endothelium, Corneal / pathology
  • Female
  • Fuchs' Endothelial Dystrophy / surgery
  • Graft Survival / physiology*
  • Humans
  • Keratoplasty, Penetrating*
  • Male
  • Retrospective Studies